CNSX:LOVE Cannara Biotech (LOVE) Stock Price, News & Analysis → Gold Mania (From Stansberry Research) (Ad) Free LOVE Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume69,070 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Cannara Biotech alerts: Email Address Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. About Cannara Biotech Stock (CNSX:LOVE)Cannara Biotech Inc. is a vertically integrated cannabis company building the largest indoor cannabis cultivation facility in Quebec, a modern and secure 625,000 square foot facility. Leveraging Quebec’s low electricity costs, Cannara will produce high-grade indoor cannabis, specializing in derivative products and brands.Read More Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. LOVE Stock News HeadlinesMay 1, 2024 | benzinga.comCannara Biotech Reports 51% YoY Revenue Increase In Q2, Wider Net LossApril 26, 2024 | msn.comPharmaCann Partners With CAMMay 4, 2024 | InvestorPlace (Ad)Elon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” April 22, 2024 | finance.yahoo.comInsider Spends US$434k Buying More Shares In LovesacApril 16, 2024 | finance.yahoo.comThe Lovesac Company (NASDAQ:LOVE) Q4 2024 Earnings Call TranscriptApril 12, 2024 | finance.yahoo.comQ4 2024 Lovesac Co Earnings CallApril 12, 2024 | finance.yahoo.comThe Lovesac Co (LOVE) Q4 2024 Earnings Call Transcript Highlights: Navigating Industry ...April 12, 2024 | finance.yahoo.comThe Lovesac Company (NASDAQ:LOVE) Shares Could Be 38% Below Their Intrinsic Value EstimateMay 4, 2024 | InvestorPlace (Ad)Elon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” April 11, 2024 | fool.comLovesac (LOVE) Q4 2024 Earnings Call TranscriptApril 9, 2024 | wsj.comCannara Biotech Inc.March 20, 2024 | finance.yahoo.comCannara Biotech Inc.'s (CVE:LOVE) Stock Been Rising: Are Strong Financials Guiding The Market?March 11, 2024 | finance.yahoo.comReturns On Capital Are Showing Encouraging Signs At Lovesac (NASDAQ:LOVE)February 25, 2024 | benzinga.comCannara Biotech Stock (OTC:LOVFF), Insider Trading ActivityFebruary 21, 2024 | finance.yahoo.comWith EPS Growth And More, Cannara Biotech (CVE:LOVE) Makes An Interesting CaseFebruary 13, 2024 | finance.yahoo.comShareholders in Lovesac (NASDAQ:LOVE) are in the red if they invested three years agoFebruary 10, 2024 | fool.com4 Appealing Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market DipFebruary 7, 2024 | benzinga.comCannara Biotech Q1 Results: Revenue, Net Income And Market Share Up, Quarter Also Marks Company's First Export SaleJanuary 30, 2024 | finanznachrichten.deCannara Biotech Inc.: Cannara Biotech Announces Record-Breaking Q1 2024 Results: Continued Robust Growth and Market ExpansionJanuary 30, 2024 | finance.yahoo.comCannara Biotech Announces Record-Breaking Q1 2024 Results: Continued Robust Growth and Market ExpansionJanuary 27, 2024 | fool.com4 Spectacular Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear-Market DipJanuary 23, 2024 | finance.yahoo.comThe past five years for Cannara Biotech (CVE:LOVE) investors has not been profitableJanuary 8, 2024 | finance.yahoo.comCannara Biotech Announces Engagement of Market Maker Services from Independent Trading Group ("ITG")January 2, 2024 | finance.yahoo.comFounder and CEO of The Lovesac Company Publishes Candid Origin StoryDecember 21, 2023 | benzinga.comCannara Biotech Stock (OTC:LOVFF) Dividends: History, Yield and DatesDecember 18, 2023 | finance.yahoo.comThe Lovesac Company Publishes 2023 ESG ReportDecember 18, 2023 | finance.yahoo.comThe Lovesac Company (NASDAQ:LOVE) Looks Just Right With A 50% Price JumpSee More Headlines Receive LOVE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cannara Biotech and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCNSX SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolCNSX:LOVE CUSIPN/A CIKN/A Webcannara.ca PhoneN/AFaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key CompetitorsAbattis BioceuticalsCNSX:ATTAgraflora Organics InternationalCNSX:AGRAAmplify Alternative Harvest ETFCNSX:MJBio-Rad LaboratoriesCNSX:BIOBlueberries MedicalCNSX:BBMView All Competitors LOVE Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Cannara Biotech own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cannara Biotech investors own include FSD Pharma (HUGE), Aurora Cannabis (ACB), Cross Timbers Royalty Trust (CRT), Emerald Health Therapeutics (EMH), HEXO (HEXO), Harvest One Cannabis (HVT) and KushCo (KSHB). How do I buy shares of Cannara Biotech? Shares of LOVE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (CNSX:LOVE) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchCould Your Accounts Be Frozen?Allegiance GoldFW: 234x GainWeiss RatingsThe Gold Grab of the CenturyColonial MetalsStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cannara Biotech Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
